PharmaPrint Inc.
The Irvine manufacturer of dietary supplements and pharmaceuticals reported a second-quarter net loss of $8 million, or 59 cents a share, compared with a net loss of $6.4 million, or 58 cents a share, for the like period last year. Revenue for the quarter ended Sept. 30 totaled $4 million. No revenue was posted for the second quarter of the previous fiscal year.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
